References
- Baldessarini R. Drugs and the treatment of psychiatric disorders. Goodman and Gilman 's The Pharmacological Basis of Therapeutics. 7th Ed, A Goodman Gilman, LS Goodman, TW Rail, F Murad. MacMillan, New York 1985; 412–423
- Martindale. The Extra Pharmacopoeia., 29th Ed, JEF Reymads. The Pharmaceutical Press, London 1989; 354, 358
- Meyler's Side Effects of Drugs, 11th Ed, MNG Dukes. Elsevier, Amsterdam, New York, Oxford 1988; 36–70
- Koren G, Bologa M, Long D, Henderson K, Feldman Y, Shear N. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol 1989; 160: 1190–1194
- Dawling S, Braithwaite RA, McAuley R, Montgomery SA. Single oral dose pharmacokinetics of clomipramine in depressed patients. Postgraduate Med J 1980; 56: 115–116
- Ben Musa A, Smith CS. Neonatal effects of maternal clomipramine therapy. Arch Dis Child 1979; 54: 405
- Ostergaard GZ, Pedersen SE. Neonatal effects of maternal clomipramine treatment. Pediatr 1982; 69: 233–234
- Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J 1982; 284: 1837–1838
- Singh S, Gulati S, Norang A, Bhakoo ON. Non narcotic withdrawal syndrome in a neonate due to maternal clomipramine therapy. J Pediatr Health 1990; 26: 110
- Committee on Drugs. American Academy of Pediatrics. The transfer of drugs and other chemicals into human breast milk. Pediatrics 1983; 72: 375–383
- Numberg HG, Prudic J. Guidelines for treatment of psychosis during pregnancy. Hosp Comm Psychiatr 1984; 35: 67–71